| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.12 | 0.5 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.5 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.054 | 0.5 |